Svetlana N. Egorova

Svetlana N. Egorova

Auto-generated profile, based on publicly available information

Svetlana N. Egorova

Kazan State Medical University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 October 2022 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
LKLiudmila A. Korol
Liudmila A. Korol
SESvetlana N. Egorova
Svetlana N. Egorova
DKDmitry Kudlay
Dmitry Kudlay
I(Ivan I. Krasnyuk (Jr.)
Ivan I. Krasnyuk (Jr.)
SSSusanna Sergeevna Sologova
Susanna Sergeevna Sologova
КАКудлай Дмитрий Анатольевич
Кудлай Дмитрий Анатольевич
Age-associated disorders, including cognitive functions, that often occur in geriatric patients, necessitate the use of novel approaches to provide appropriate medical care, pharmacoprophylaxis and pharmacotherapy among them. At the same time, an important objective of the national healthcare system is not only stimulating of pharmaceutical companies and pharmacies to expand the range of medicines intended for elderly patients, but also increasing availability of medicinal products, including the integration of extemporaneous formulations into clinical practice. Presented review considers several features of the regulation of the use of extemporaneous formulations in the treatment of geriatric patients. Examples of prescriptions that are used in Russian medical practice and are of the greatest interest in the treatment of elderly patients are also presented.

1 May 2025 in Regulatory Research and Medicine Evaluation
Verified
Journal Article
Open access
PDF file
VKV. V. Kosenko
V. V. Kosenko
YNYa. S. Novikov
Ya. S. Novikov
SES. N. Egorova
S. N. Egorova
VEVladimir Evteev
Vladimir Evteev
NBN. D. Bunyatyan
N. D. Bunyatyan
INTRODUCTION. Syrups are an important dosage form used in medical practice, particularly in paediatrics. As of January 2024, there are 212 medicinal products formulated as syrups approved in the Russian Federation. The effi­cacy, safety, and quality of syrups are determined by their composition, including excipients.AIM. This study aimed to analyse and systematise data on the role and safety of excipients in syrups included in the Russian State Register of Medicines.DISCUSSION. This article reviews the major groups of excipients present in syrups, including sweeteners, preservatives, solvents, thickeners, pH modifiers, buffering agents, antioxidants, and colourants. The most prevalent group of excipients is sweeteners, including sucrose (66.51%), sorbitol (29.25%), and sodium saccharin (10.85%). Sucrose contributes to tooth decay and is contraindicated in patients with diabetes and obesity. Sorbitol may cause gastrointestinal disorders. Data on the long-term safety of artificial sweeteners are contradictory. Therefore, sweeteners should be selected rationally. The most widely used preservatives are parabens, including methylparaben (31.60%) and propylparaben (20.28%). Propyl­paraben exhibits potential oestrogenic activity, which makes methylparaben the para­ben of choice. Solvents and co-solvents include water, glycerol (25.94%), ethanol (24.53%), and propylene glycol (20.75%). Ethanol and propylene glycol can cause severe central nervous system disorders. The most commonly used thickener is hydroxyethyl cellulose (5.19%). Cellulose derivatives are considered safe but may have a laxative effect if consumed in excess. The most popular colourant is Sunset Yellow (7.54%). The lack of data on the safety of many colourants emphasises the need for their rational selection.CONCLUSIONS. By analysing summaries of product characteristics and patient information leaflets for syrups available in the Russian State Register of Medicines, the authors have systematised data on the role, safety, and acceptable daily intake of excipients in used syrups, classified these excipients, and calculated the frequency of their use. The findings suggest that the current approaches to selecting excipients for syrups should be revised to minimise potential risks and to enhance the safety of medicinal products.

1 January 2022 in Problems of Biological, Medical and Pharmaceutical Chemistry
Verified
Journal Article
Closed access
VKV.A. Kurkin
V.A. Kurkin
NVN.A. Volkova
N.A. Volkova
OPO.E. Pravdivtseva
O.E. Pravdivtseva
AKA.V. Kurkina
A.V. Kurkina
PTP.V. Trifonova
P.V. Trifonova
SES.N. Egorova
S.N. Egorova

28 August 2024 in Regulatory Research and Medicine Evaluation
Verified
Journal Article
Open access
PDF file
MMMark Aleksandrovich Mandrik
Mark Aleksandrovich Mandrik
ISIvan Alexandrovich Sadkovskii
Ivan Alexandrovich Sadkovskii
ЛКЛ. А. Король
Л. А. Король
SES. N. Egorova
S. N. Egorova
I(Ivan I. Krasnyuk (Jr.)
Ivan I. Krasnyuk (Jr.)
ABA. V. Bykov
A. V. Bykov
INTRODUCTION. Currently, stakeholders across the Russian medical and pharmaceutical community are focusing on the restoration of national pharmaceutical compounding. The Russian pharmaceutical compounding market, with its great potential for growth, requires highly qualified professionals able to ensure the operation of compounding pharmacies and the proper quality of extemporaneous medicinal products. The effectiveness of training for such specialists can be improved by analysing the experience of educational institutions in countries with developed pharmaceutical compounding systems.AIM. This study aimed to analyse the distinguishing features of training for pharmaceutical compounding specialists, as well as determine the main trends in pharmaceutical compounding education in leading international academic institutions.MATERIALS AND METHODS. The study used methods of logical, comparative, structural, and content analysis. The analysis covered 106 pharmacy and pharmacology curricula of the top-25 higher education providers from the QS World University Rankings by Quacquarelli Symonds. The curricula were analysed using open data published online, particularly, on the official websites of the selected universities.RESULTS. The article presents the distinguishing features of pharmaceutical compounding education at different academic qualification levels; these features include the requirements for applicants, time to degree, competence standards, structure of exams, and specifics of students’ professional engagement, with consideration of the national context. The key trends in the education of specialists in pharmaceutical compounding include a decrease in training time for mid-level specialists; a tendency towards concentrating on clinical disciplines due to the expansion of the roles of pharmacy professionals; a growing focus on specialisation in the areas of paediatric, dental, sterile, veterinary, radiopharmaceutical, and orphan drug compounding; increasing use of simulated practice experiences and online learning technologies; and the development of continuing professional education systems.CONCLUSIONS. Pharmaceutical education programmes of leading international educational organisations include disciplines related to extemporaneous compounding. Current international trends—pharmaceutical education with further specialisation in extemporaneous compounding, integration of simulation technologies and online learning into the educational process, and development of continuing professional education—coincide with the development directions of pharmaceutical education in the Russian Federation. Whereas international pharmacy specialists complete additional professional education programmes to gain an additional specialisation in the extemporaneous preparation of paediatric medicinal products, sterile dosage forms, chemotherapy products, radiopharmaceuticals, veterinary products, and dental products, Russian specialists can acquire these additional competencies through further education programmes at the levels of advanced training and residency.

2 March 2021 in Pharmacy & Pharmacology
Verified
Journal Article
Open access
PDF file
VIV. A. Izrafilova
V. A. Izrafilova
SES. N. Egorova
S. N. Egorova
GGG. Kh. Garifullina
G. Kh. Garifullina
TAT. A. Akhmetova
T. A. Akhmetova
Cure of allergy symptoms reported by a patient with the help of non-prescription antiallergic drugs, is one of the important aspects of a responsible self-medication.The aimof the study is to assess the peculiarities of consumers’ behavior as pharmacy visitors, when choosing non-prescription antiallergic drugs, and to identify potential problems of pharmaceutical counseling for allergy symptoms regarding the responsible self-medication.Materials and methods. Sociological survey in the form of a questionnaire; graphoanalytical and comparative analyses.Results. The profile of an over-the-counter antiallergic drugs buyer in the pharmacies of Kazan was assessed in the following way: it is a woman aged 18–44 of a middle level of income, having a family of 3–4 people, ready to spend from 101 to 500 rubles on the purchase of antiallergic drugs, buying anti-allergic drugs not for the first time. The main reasons to seek for treatment were skin rash, redness and itching, which had also been observed in the past. The allergic nature of the disease had already been confirmed by the doctor. For the average consumer of over-the-counter antiallergic drugs, the most important criteria for choosing a medicine were: efficiency, safety, the doctor’s recommendations and price. The medicines were purchased for the visitors themselves or their children. The customers were satisfied with the choice of non-prescription antiallergic medicines available in the pharmacy. The visitors generally trusted the pharmacists’ advice and recognized them as health professionals, but considered that the main goal was not only to provide a pharmaceutical care, but also to profit from the sale of the drugs. The following flaws of pharmaceutical counseling when dispensing non-prescription antiallergic drugs, were identified: an improper diagnosis by a pharmaceutical specialist, the lack of recommendations to consult a doctor, incomplete provision of information on the use, storage, and the possibility of interaction with other drugs and food.Conclusion. Misdiagnosis and incomplete provision of information by pharmaceutical specialists on antiallergic the drugs that are approved for the over-the-counter dispensing, require the implementation of a pharmaceutical consultation algorithm for the visitors contacting a pharmacy with allergy symptoms.

12 August 2022 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
LKLiudmila A. Korol
Liudmila A. Korol
SESvetlana N. Egorova
Svetlana N. Egorova
DKDmitry Kudlay
Dmitry Kudlay
I(Ivan I. Krasnyuk (Jr.)
Ivan I. Krasnyuk (Jr.)
SSSusanna Sergeevna Sologova
Susanna Sergeevna Sologova
КАКудлай Дмитрий Анатольевич
Кудлай Дмитрий Анатольевич
The worlds older population is growing dramatically. At the same time, ensuring an appropriate high standard of living for the elderly by reducing of morbidity and disability of geriatric patients is one of the main objectives of the modern healthcare system. However, changes associated with body aging necessitate application of novel approaches to the correction of pharmacotherapy and usage of specialized dosage forms. Such medicinal products provide both an appropriate therapeutic effect and facilitate their use. Presented review considers several features of pharmacotherapy of geriatric patients.